- Home
- HYPR vs AEI Comparison
HYPR vs AEI Comparison
Compare HYPR & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HYPR | AEI |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.5M | 119.4M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HYPR | AEI |
|---|---|---|
| Price | $1.17 | $1.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.45 | N/A |
| AVG Volume (30 Days) | ★ 495.1K | 15.3K |
| Earning Date | 03-18-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 23.21 | ★ 93.40 |
| EPS | ★ N/A | N/A |
| Revenue | $13,563,000.00 | ★ $16,238,200.00 |
| Revenue This Year | $35.37 | N/A |
| Revenue Next Year | $18.33 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.22 | N/A |
| 52 Week Low | $0.53 | $0.70 |
| 52 Week High | $2.22 | $4.55 |
Technical Indicators
Market Signals| Indicator | HYPR | AEI |
|---|---|---|
| Relative Strength Index (RSI) | 52.80 | 44.82 |
| Support Level | $1.04 | $1.13 |
| Resistance Level | $1.37 | $2.11 |
| Average True Range (ATR) | 0.10 | 0.18 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 41.18 | 63.29 |
Price Performance
Historical ComparisonAbout HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.